Study finds one-third of American and European primary care patients at high risk for sleep apnea

May 22, 2001

Researchers reported at the American Thoracic Society 2001 International Conference that about one-third of primary care patients in the United States and Europe have risk factors for sleep apnea, a disorder in which a person stops breathing during sleep. The study, presented May 23, is the first direct comparison of primary care populations among countries in regard to these risk factors, such as persistent snoring and daytime sleepiness.

Specifically, 36 percent of U.S. patients and 26 percent of European patients report risk factors for sleep apnea. Overall, U.S. patients have greater daytime sleepiness and obesity, as well as a composite score for high risk for sleep apnea, despite similar rates with Europeans for chronic snoring. About 31 percent of those surveyed say they experience excessive daytime sleepiness, with a higher prevalence in the United States (34.6 percent versus 10.1 percent in Europe).

The study finds variations among genders. Men have greater overall risk than women, independent of where they live. However, U.S. women have a higher risk of sleep apnea than their European counterparts, while U.S. and European men have a more similar risk. Aging results in less difference among genders and a higher European rate of persistent snoring, but overall risk still remains higher in the United States.

Reports of sleepiness while driving an automobile are more common in U.S. patients. Eighteen percent of Americans report they drive while sleepy at least three to four times a week, while 8 percent of Europeans report driving while sleepy.

The researchers say these findings indicate a need for more resources for recognition and management of sleepiness and sleep apnea on both continents. "Sleepiness, fatigue, and inattention are major causes not only of car crashes, but also of personal accidents and workplace errors," says Kingman Strohl, an author on the study and a professor of medicine at Case Western Reserve University's School of Medicine and the Louis Stokes Cleveland Veterans Affairs Medical Center. "Reductions in sleepiness can reduce these adverse events, but also increase the sense of wellness," he says.

The findings are based on 6,245 questionnaires completed by patients who were 15 years of age and older at 34 primary care sites in the United States, Spain, and Germany.
-end-


Case Western Reserve University

Related Sleep Apnea Articles from Brightsurf:

Sleep apnea may be risk factor for COVID-19
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic.

Untreated sleep apnea is associated with flu hospitalization
As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions.

Losing tongue fat improves sleep apnea
Using magnetic resonance imaging (MRI) to measure the effect of weight loss on the upper airway in obese patients, researchers found that reducing tongue fat is a primary factor in lessening the severity of OSA.

More cancer cases among women with sleep apnea
Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows.

New evidence on the association of shortened sleep time and obstructive sleep apnea with sleepiness and cardiometabolic risk factors
A new study in the journal CHEST® may change the way we think about sleep disorders.

Synthetic cannabis-like drug reduces sleep apnea
A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea.

Inflammation may precede sleep apnea, could be treatment target
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

Concerns that sleep apnea could impact healthspan
The number of people with obstructive sleep apnea has steadily increased over the past two decades.

Sleep apnea and insomnia combination linked with depression
A new study found that men with sleep apnea and insomnia have a higher prevalence and severity of depressive symptoms than men with sleep apnea or insomnia alone.

Anti-nausea drug could help treat sleep apnea
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

Read More: Sleep Apnea News and Sleep Apnea Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.